Business · 08/11/2007

FDA Announces Public Meeting to Discuss Proposed Rule on Ozone-Depleting Substances and Epinephrine

The FDA is hosting a public meeting to gather comments on a proposed rule that would remove the essential-use designation for epinephrine-containing oral pressurized metered-dose inhalers, following the publication of the rule in the Federal Register on September 20, 2007.